Results 121 to 130 of about 225,165 (200)
This study aimed to investigate endocrinologic test values and the response to treatment of two commonly encountered causes of endocrinopathic laminitis, equine Cushing's disease (ECD) and equine metabolic syndrome (EMS), in a veterinary practice setting.
Thomas McGowan +11 more
core +1 more source
Managing Equine Metabolic Syndrome
Equine metabolic syndrome (EMS) is a relatively new disease that we are still learning about. There are many things to investigate when dealing with a new disease: causes, predispositions, symptoms, secondary issues, treatments, and prevention.
Meldrum, Abigail, Hoopes, Karl
core
Renal tubular acidosis: A ‘basic’ disorder
Equine Veterinary Education, Volume 38, Issue 7, Page 365-366, July 2026.
H. J. Mason, L. G. Arroyo
wiley +1 more source
Effects of equine cloned embryo aggregation on in vivo development.
No significant differences were found (Fisher's exact test ...
Romina Jimena Bevacqua (661153) +4 more
core +1 more source
Starvation in horses presents critical welfare, economic, and management challenges with underlying molecular mechanisms of metabolic modification and recovery left poorly defined.
Madeline M. P. Austin +3 more
doaj +1 more source
Objective-To investigate the effects of acute exercise and long-term training on Na(+),K(+)-ATPase content, mRNA isoforms, and protein concentration in equine muscle. Animals-6 Standardbreds.
de Graaf-Roelfsema, E. +10 more
core +1 more source
The aim of this study was to find out how many and which of the herbs used for horses that have been scientifically studied with results to justify the use.
Fors, Maria
core
Equine metabolic syndrome (EMS) is a metabolic disorder characterized by excessive obesity and or/regional adiposity, insulin resistance (IR) and prior or current laminitis.
SMIESZEK, Agnieszka +4 more
core +1 more source
Effects of feeding and exercise changes on equine metabolic syndrome (EMS)
H. Gehlen, S. Liertz, R. Merle
semanticscholar +1 more source
Ertugliflozin is a sodium-glucose co-transporter-2 inhibitor that has demonstrated promise as a treatment for hyperinsulinaemia in horses. Despite the frequent use of ertugliflozin in equine clinical practice, the pharmacokinetics of this drug in horses ...
Naomi C. Kirkwood +5 more
doaj +1 more source

